GALENA BIOPHARMA-Wert mit Zukunft?

Mark W. Schwartz, Ph.D., President and Chief Executive Officer will present a corporate update at the Oppenheimer 26th Annual Healthcare Conference


http://globenewswire.com/news-release/2015/11/30/...e-Conference.html  

http://globenewswire.com/news-release/2015/12/04/...ive-Lawsuits.html  

http://globenewswire.com/news-release/2015/12/08/...d-Exposition.html  

https://www.google.de/...ICdnqiO7Hoeg&sig2=TSF_fXKYJTZXlG2yymmSLA  

Updates on Divestiture Costs


http://www.streetinsider.com/Corporate+News/...re+Costs/11179800.html  

http://globenewswire.com/news-release/2016/01/06/...and-Warrants.html  

ca. 20 mio shares zu 1.1 $ ? versteh ich das richtig ? was sind die 0.6 zu 1.44 $ ? kann mir das jemand erklären ? steht so auf dwer Homepage von Galena ..
was meint ihr , wie wird sich der Kurs nun entwickeln ?  

Ich habe eine Mail an GALE geschrieben bzgl. der KE... und klargestellt, dass alle Shareholder richtig verarscht wurden sind damit.. besonders im Hinblick auf die momentane Lage der Märkte.

Es gibt einige Meilensteine, die im Q1 und Q2 auf uns warten.. mal sehen

hier ist erstmal die Antwort von GALENA:

Patrick,
As a shareholder, I understand your frustration with our choice of timing during these unforeseen market conditions.  As you can see on our website, we have updated our current presentation to reflect our vast and expanding pipeline as well as our expected milestones and spend for the year.  



http://investors.galenabiopharma.com/investors/...ations/default.aspx



As such, it was important for us to secure our cash balance and ensure the company remains financially strong for 2016.  We expect to make progress over the course of the year and sincerely appreciate your support.



Warm regards,

Remy  

Remy Bernarda
SVP, Investor Relations & Corporate Communications
Galena Biopharma, Inc.

 

SAN RAMON, Calif., Jan. 07, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major medical needs, today announced the pricing of an underwritten public offering of 19,772,727 units at a public offering price of $1.10 per unit, for total gross proceeds of $21.75 million. Each unit consists of one share of common stock and 0.6 of a warrant to purchase a share of common stock at an exercise price of $1.42 per share. The warrants are immediately exercisable and expire on the fifth anniversary of the date of issuance. The shares of common stock and warrants are immediately separable and will be issued separately.

http://globenewswire.com/news-release/2016/01/07/...tml?parent=799984

 

das sind die Warrants die es im Unit mit der Aktie zusammen gibt !

Each unit consists of one share of common stock and 0.6 of a warrant to purchase a share of common stock at an exercise price of $1.42 per shares

 

ärgere mich gerade, dass ich kurz vor SL-Fishing rein bin :-((..


12Cent !! Mist trotz das die Posi grün ist  

meine irgendwo gelesen zuhaben, dass du bei GALE dabei bist...


oder hast du schon die Leine gezogen gestern beim SL-Fishing...




 

gibt es hier auch noch einige um die ca. 1,08$ bis 1,25$ und um die ca. 1,52$

bis 1,68$, der RSI mit 14 stark überverkauft und unten raus aus dem BB


also das schreit förmlich nach einer techn. Gegenreaktion..




 

zitat;

SAN RAMON, Calif., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company committed to the development and commercialization of targeted oncology therapeutics that address major unmet medical needstoday announced that Mark W. Schwartz, Ph.D., President and Chief Executive Officer will present a corporate update at NobleCon12

http://www.econotimes.com/...welfth-Annual-Investor-Conference-141091  

http://www.streetinsider.com/Corporate+News//...estones/11215655.html  

http://seekingalpha.com/article/...ccine-a-matter-of-signal-integrity  

unbedingt lesen:

http://www.houstonchronicle.com/news/health/...ancer-away-6514603.php

 

Galena Biopharma Presents Observational Study Data in Gastric Cancer Patients at the ASCO 2016 Gastrointestinal Cancers Symposium


http://www.globenewswire.com/news-release/2016/01/...s-Symposium.html  

http://www.nasdaq.com/de/symbol/gale/after-hours  

schauen was die Cowboys mit dieser News machen werden....

hoffe auf Gap-close, ob da was draus wird ??  

http://www.wallstreet.org/...additional-patent-for-neuvax-nasdaqgale/  

mit Galena Biopharma Inc. Interim GC Thomas J. Knapp


http://www.bna.com/galena-biopharma-inc-n57982066912/  

A Matter Of Signal Integrity (Part 2)

http://seekingalpha.com/article/...ine-matter-signal-integrity-part-2  

https://biz.yahoo.com/e/160216/gale8-k.html  

Gale is Loaded with Catalysts

http://my-gale.com/catalysts.html